SCHEMBL2129042

SCHEMBL2129042

CCOC(=O)c1c(C)cc(Cl)nc1Cl

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.51
CYP3A4 P08684 3/20 0.51
TDP1 Q9NUW8 1/20 0.51
ALDH1A1 P00352 4/20 0.49
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
HPGD P15428 2/20 0.47
NR1H2 P55055 1/20 0.47
NR1H3 Q13133 1/20 0.47
MAPK1 P28482 1/20 0.47
KDM4E B2RXH2 3/20 0.47
TAAR1 Q96RJ0 1/20 0.46
USP2 O75604 1/20 0.45
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44
CA14 Q9ULX7 1/20 0.44
CYP1A2 P05177 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1085394 0.88 SMN1; SMN2 (0.50) SMN1; SMN2CYP3A4TDP1ALDH1A1HPGD
SCHEMBL10736055 0.86 SMN1; SMN2 (0.61) SMN1; SMN2CYP3A4TDP1ALDH1A1MEN1
SCHEMBL612852 0.85 SMN1; SMN2 (0.52) SMN1; SMN2CYP3A4TDP1ALDH1A1HPGD
SCHEMBL31644242 0.85 SMN1; SMN2 (0.52) SMN1; SMN2CYP3A4TDP1ALDH1A1HPGD
SCHEMBL25246581 0.85 SMN1; SMN2 (0.47) SMN1; SMN2CYP3A4TDP1ALDH1A1HPGD
SCHEMBL24773784 0.85 SMN1; SMN2 (0.51) SMN1; SMN2CYP3A4TDP1ALDH1A1HPGD
SCHEMBL23180596 0.85 HTT (0.44) SMN1; SMN2CYP3A4TDP1ALDH1A1HPGD
SCHEMBL18518173 0.84 GPR35 (0.44) SMN1; SMN2CYP3A4TDP1ALDH1A1MEN1
SCHEMBL15525056 0.84 SMN1; SMN2 (0.46) SMN1; SMN2CYP3A4TDP1ALDH1A1HPGD
SCHEMBL1085042 0.82 ALDH1A1 (0.50) SMN1; SMN2CYP3A4ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3318556-A1 SUBSTITUTED 6-AMINO-NICOTINAMIDES AS KCNQ2/3 MODULATORS Grünenthal GmbH (DE) 2018-05-09 EP disclosed
EP-2630123-B1 SUBSTITUTED 6-AMINO-NICOTINAMIDES AS KCNQ2/3 MODULATORS GRUENENTHAL GMBH (DE) 2017-12-20 EP disclosed
EP-2888233-B1 SUBSTITUTED 6-AMINO-NICOTINAMIDES BEARING AN OH-CONTAINING GROUP AS KCNQ2/3 MODULATORS GRUENENTHAL GMBH (DE) 2016-09-28 EP disclosed
US-9278103-B2 Substituted 6-amino-nicotinamides as KCNQ2/3 modulators Grünenthal GmbH (DE) 2016-03-08 US disclosed
US-9168259-B2 Substituted 6-amino-nicotinamides as KCNQ2/3 modulators Grünenthal GmbH (DE) 2015-10-27 US disclosed
EP-2888233-A1 SUBSTITUTED 6-AMINO-NICOTINAMIDES BEARING AN OH-CONTAINING GROUP AS KCNQ2/3 MODULATORS Grünenthal GmbH (DE) 2015-07-01 EP disclosed
US-20140213569-A1 Substituted 6-amino-nicotinamides as KCNQ2/3 modulators GRUNENTHAL GMBH (DE) 2014-07-31 US disclosed
WO-2013156154-A1 SUBSTITUTED 6-AMINO-NICOTINAMIDES BEARING AN OH-CONTAINING GROUP AS KCNQ2/3 MODULATORS Grünenthal GmbH (DE) 2013-10-24 WO disclosed
US-8552200-B2 Substituted 6-amino-nicotinamides as KCNQ2/3 modulators GRUENENTHAL GMBH (DE) 2013-10-08 US disclosed
EP-2630123-A1 SUBSTITUTED 6-AMINO-NICOTINAMIDES AS KCNQ2/3 MODULATORS Grünenthal GmbH (DE) 2013-08-28 EP disclosed
US-20120258947-A1 SUBSTITUTED 6-AMINO-NICOTINAMIDES AS KCNQ2/3 MODULATORS GRUNENTHAL GMBH (DE) 2012-10-11 US disclosed
US-20120101079-A1 SUBSTITUTED 6-AMINO-NICOTINAMIDES AS KCNQ2/3 MODULATORS GRUNENTHAL GMBH (DE) 2012-04-26 US disclosed
WO-2012052167-A1 SUBSTITUTED 6-AMINO-NICOTINAMIDES AS KCNQ2/3 MODULATORS Grünenthal GmbH (DE) 2012-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140213569-A1 Substituted 6-amino-nicotinamides as KCNQ2/3 modulators KCNQ2, KCNQ1, KCNQ3 SMN1; SMN2 808/4885CYP3A4 1523/4885TDP1 3619/4885
US-20120101079-A1 SUBSTITUTED 6-AMINO-NICOTINAMIDES AS KCNQ2/3 MODULATORS KCNQ2, KCNQ1, KCNQ3 SMN1; SMN2 808/4885CYP3A4 1523/4885TDP1 3619/4885
US-20120258947-A1 SUBSTITUTED 6-AMINO-NICOTINAMIDES AS KCNQ2/3 MODULATORS KCNQ2, KCNQ1, KCNQ3 SMN1; SMN2 808/4885CYP3A4 1523/4885TDP1 3619/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.